Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Inrebic Approval Is A Boost For Myelofibrosis And Celgene's Buyer Bristol
Aug 16 2019
•
By
Mandy Jackson
Inrebic is only the second drug, after Jakafi, approved for myelofibrosis in the US. • Source: Shutterstock
More from New Products
More from Scrip